Invention Application
- Patent Title: MONOCLONAL ANTIBODIES AGAINST HER2
-
Application No.: US17369542Application Date: 2021-07-07
-
Publication No.: US20220169738A1Publication Date: 2022-06-02
- Inventor: Bart DE GOEIJ , Simone DE HAIJ , Thilo RIEDL , Rene HOET , Ole BAADSGAARD , Jan VAN DE WINKEL , David SATIJN , Paul PARREN , Aran Frank LABRIJN , Joyce MEESTERS , Janine SCHUURMAN , Edward N. VAN DEN BRINK
- Applicant: GENMAB A/S
- Applicant Address: DK Copenhagen V
- Assignee: GENMAB A/S
- Current Assignee: GENMAB A/S
- Current Assignee Address: DK Copenhagen V
- Priority: DKPA201000467 20100527,DKPA201100312 20110420,EPPCT/EP2011/056388 20110420
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/32
Abstract:
Isolated monoclonal antibodies which bind to human epidermal growth factor receptor 2 (HER2), and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed.
Information query
